Priyatham S. Mettu, MD Priyatham S. Mettu, MD

Priyatham S. Mettu, MD

Ophthalmologist, Retinal Specialist

4.7 out of 5  (190 ratings, 17 reviews)
Duke Health Provider What's this?
Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy

Click to see a list of accepted insurance plansHide accepted insurance plans
Contact
Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy

Click to see a list of accepted insurance plansHide accepted insurance plans

Contact
Profile
ABOUT ME

As a medical retina specialist, I am passionate about providing state-of-the-art care to patients with age-related macular degeneration, diabetic retinopathy, retinal vein occlusion, and other macular diseases. I approach each patient as an individual and strive to provide care that addresses his or her unique needs and goals. For each of my patients, I carefully consider exam findings and results of advanced retinal imaging studies and use this information to design a personalized treatment strategy. In my role as a physician, I enjoy most the enduring relationships that I build with patients and their families, and the opportunities that I have to make a lasting positive impact on their lives. In addition to patient care, I maintain an active clinical and laboratory research program. I am actively involved in clinical trials of new treatments for age-related macular degeneration and diabetic retinopathy, and in studies of new imaging technologies for improved diagnosis and monitoring of macular diseases. Outside of work, I enjoy spending time with my wife and children.

LANGUAGES I SPEAK
English
Training
EDUCATION
MD, Duke University School of Medicine, 2005
RESIDENCY
Ophthalmology, Duke Eye Center, 2009 (Chief Resident, 2010)
FELLOWSHIP
Clinical and Research Fellowship, Medical Retina, Duke Eye Center, 2010-2012
BOARD CERTIFICATION
American Board of Ophthalmology, Ophthalmology
Clinical Focus and Research
MY RESEARCH INTERESTS

I am a translational clinician-scientist within the Duke Center for Macular Diseases, where I fully embrace our mission to “Discover. Invent. Transform.” My scientific research program is focused on understanding the role of inflammation in the development of severe wet macular degeneration, which affects up to 40% of patients and is difficult to treat with available medications. In the laboratory, we are using specialized disease models to identify the specific mechanisms of this disease, with the explicit goal of discovering novel targets for future therapies. I am passionate about opportunities to innovate, and our group of clinician-scientists is actively collaborating with Duke engineers to develop novel imaging devices and with Duke chemists to invent new drugs, for improved diagnosis and treatment of macular diseases. Finally, I am an active clinical researcher. In addition to participating in industry-sponsored clinical trials of novel drugs for age-related macular degeneration and diabetic retinopathy, I lead “home-grown” studies (originating here at Duke) to develop new treatment approaches and biomarker technologies to transform the care of patients with macular diseases.

PUBLICATIONS
View Priyatham Mettu's publications on PubMed
Ratings and Reviews

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more about our survey process. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Overall provider rating
4.7 out of 5 (190 ratings, 17 reviews)
PATIENT REVIEWS
Patient comments are gathered from our Press Ganey Patient Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
Industry Relationships and Collaborations
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
  • Eyedesis Biosciences
  • Optovue
  • Stealth Biotherapeutics
  • Valeant Pharmaceuticals Internatl